MD Medical Group IPJSC (“MD Medical”, "Group" or the "Company"; MOEX: MDMG), a leading Russian private healthcare provider, announces its operating and unaudited financial results for Q1 2026.

Key financial highlights for Q1 2026:

• The Group’s total revenue grew by 32.1% y-o-y to RUB 11,834 million, driven by strong uptake of delivery services in Moscow hospitals and IVF services in the Group’s clinics as well as contribution from the newly integrated Expert medical centres network (17% of total revenue).

• Like-for-like (LFL) revenue increased by 9.2% y-o-y to RUB 9,781 million.

• Revenue of Moscow hospitals rose by 9.5% y-o-y to RUB 4,850 million, primarily due to high delivery revenue growth (+36.7% y-o-y).

• Revenue of the Group’s regional hospitals grew by 30.3% y-o-y to RUB 3,115 million, driven by higher revenue from out-patient treatments, in-patient care in surgeries and obstetrics and gynecology, including due to contribution of new medical centres acquired in 2025, as well as sustainable demand for deliveries.

• Revenue from out-patient clinics in Moscow increased by 16.6% y-o-y to RUB 1,028 million, reflecting strong demand for out-patient care, including that at our new clinics launched in 2024 and 2025 that are reaching their target capacity.

• Revenue from out-patient clinics in other regions surged by 2.3 times y-o-y to RUB 2,797 million, mainly due to 4x out-patient revenue growth including on the back of contributions from newly opened and acquired clinics. 

• As at the end of Q1 2026, the Group’s cash position stood at RUB 4,028 million. The Company has not raised any debt financing.

• In Q1 2026, total Capex was RUB 1,625 million consisting among others of final payments for the acquisition of real estate for a new hospital in Moscow.

Key operational highlights for Q1 2026:

• Total out-patient treatments increased by 2.1 times y-o-y to 1,301,981, with the average ticket up 11% y-o-y to RUB 7.5 thousand in Moscow and up 6.7% y-o-y to RUB 2.9 thousand in other regions.

• Total in-patient treatments decreased by 4.5% y-o-y to 34,835, the number of surgeries grew 36.3%. Average in-patient care ticket was up 4.3% y-o-y to RUB 127.3 thousand in Moscow and up 16.2% y-o-y to RUB 55.6 thousand in other regions.

• Total deliveries increased by 14.2% y-o-y to 3,194, with the average ticket up 6.8% y-o-y to RUB 662.5 thousand in Moscow and up 21.1% y-o-y to RUB 290.8 thousand in other regions.

• Total IVF punctures decreased by 2.1% y-o-y to 4,699, the number of frozen embryo transfers grew 3.4% that inter alia caused the average ticket up 17.4% to RUB 393.9 thousand in Moscow and up 10.1% y-o-y to RUB 336.2 thousand in other regions.

Key events during Q1 2026 and after the reporting period:

Expansion of the clinic in Tula. On 1 April 2026 года the total area of the Mother and Child Clinic in Tula, which specializes in a wide range of medical services for women's health, including pregnancy management and IVF, increased by 95 square meters and now covers the total area of 636 square meters. The updated clinic will increase the patient flow and capacity of the Group's popular clinic from 24,000 visits to 42,000 visits per year. Investments in the clinic expansion amounted to RUB 18.5 mln.

Opening new clinic in Moscow. On 20 March 2026 MD Medical Group opened its clinic in Kurkino district of Moscow, which specializes in a wide range of medical services for women's health, with a total area of 289 sq m. The clinic has a capacity of 42,000 appointments per year. Total investment in opening and equipping the clinic came to RUB 55 million.

New clinic in Novorossiysk launched. On 9 February 2026 MD Medical Group opened Mother & Child Novorossiysk clinic spanning 206 sq m and specializing in a wide range of medical services for women's health. The new clinic will operate in close association with the Group's nearby multidisciplinary medical centre in Anapa, which opened in 2024. The clinic's capacity allows for 24,000 out-patient visits per year. Total investment in opening and equipping the clinic came to RUB 60 million.

MD Medical CEO Mark Kurtser said:

“The Company delivered strong performance in Q1 2026, with the Group’s total revenue increasing by 32%. Despite the high base from the previous year, we maintained a growth trend, supported by our diversification across medical services, formats and geographies. This ensures resilience to changes in demand and the external environment.

We are sincerely grateful to our patients for continuing to choose us at one of the most important moments in their lives when they seek support in bringing a new life into the world. Deliveries at our hospitals continue to grow: in Q1, the number of deliveries increased by 14% y-o-y, while revenue in this segment rose by 33%. 

We also sustained our traditional revenue growth in the IVF segment, which rose by 11% in Q1. However, amid the ongoing trend towards delayed motherhood, the revenue mix shifted towards frozen embryo transfers, which do not require new IVF punctures.

The key drivers behind the strong double-digit growth in out-patient revenue were diagnostic and treatment services, obstetrics, gynaecology, and paediatrics.

The decline in in-patient days reflects a broader trend towards shorter hospital stays, driven by more intensive treatment protocols, the adoption of innovative techniques, and changes in healthcare standards introduced by the regulator across several areas. This enables us to reallocate capacity and expand the volume of high-demand maternity services. At the same time, the number of surgical procedures (particularly in regional hospitals offering unique operations) continues to grow, contributing to higher in-patient revenue.

We keep up the momentum, increasing the availability of our services in Moscow and beyond. We maintain a strong financial position and stable growth in our financial performance, which enables us to pay dividends on a regular basis. In mid-May this year, we plan to submit to the Board of Directors a proposal on the distribution of profit for 2025.”

***

Notes:
1.     Data is based on management accounts
2.     Minor variations in calculation of totals, subtotals and/or percentage change are due to rounding of decimals

***

About MD Medical Group

MD Medical Group is a leading provider in the highly attractive Russian private healthcare service market. Today, the Company manages 90 state-of-the-art healthcare facilities, including 14 multidisciplinary hospitals and 76 out-patient clinics in 35 regions of the Russian Federation. In 2025, MD Medical Group's revenue amounted to RUB 43.5 bln. while EBITDA stood at RUB 13.3 bln. The Company's ordinary shares are traded on Moscow Exchange (MOEX: MDMG).